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Remnant Lipoproteins and Accelerates
Progressive Atherosclerosis,
But Not Xanthoma Formation,
in Gene-Modiﬁed Minipigs
Jeong Shim, MD,a,b Christian Bo Poulsen, MD, PHD,a,b Mette K. Hagensen, MSC, PHD,a,b Torben Larsen, MSC, PHD,c
Peter M.H. Heegaard, MSC, PHD,d Christina Christoffersen, MD, PHD, DMSC,e Lars Bolund, MD, DMSC,f
Mette Schmidt, DVM, PHD,g Ying Liu, MSC, PHD,c Juan Li, MSC, PHD,c Rong Li, MSC, PHD,c
Henrik Callesen, DVM, PHD, DRVETSCI,c Jacob F. Bentzon, MD, PHD,a,b,h Charlotte B. Sørensen, MSC, PHDa,bVISUAL ABSTRACTShim, J. et al. J Am Coll Cardiol Basic Trans Science. 2017;2(5):591–600.HIGHLIGHTS
 APOE-deﬁcient Yucatan minipigs were
created by recombinant adeno-associated
virus mediated gene targeting in porcine
ﬁbroblasts followed by somatic cell
nuclear transfer.
 APOEL/L minipigs displayed increased
plasma cholesterol and accumulation of
APOB48-containing chylomicron
remnants on low fat-diet, which was
signiﬁcantly accentuated upon feeding a
high-fat, high-cholesterol diet.
 APOEL/L minipigs showed accelerated
progressive atherosclerosis but not
xanthoma formation indicating that
remnant lipoproteinemia does not induce
early lesions but is atherogenic in
pre-existing atherosclerosis.
ABBR EV I A T I ON S
AND ACRONYMS
APOB = apolipoprotein B
APOE = apolipoprotein E
cDNA = complementary DNA
HFHC = high-fat
high-cholesterol
IDL = intermediate-density
lipoprotein
LAD = left anterior descending
(coronary artery)
LDL = low-density lipoprotein
LDLR = low-density lipoprotein
receptor
LF = low-fat
Neo = neomycin
rAAV = recombinant
adeno-associated virus
SMC = smooth muscle cell
VLDL = very-low-density
lipoprotein
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t reDeﬁciency of apolipoprotein E (APOE) causes familial dysbetalipoproteinemia in humans resulting in a higher
risk of atherosclerotic disease. In mice, APOE deﬁciency results in a severe atherosclerosis phenotype, but it is
unknown to what extent this is unique to mice. In this study, APOE was targeted in Yucatan minipigs. APOE/
minipigs displayed increased plasma cholesterol and accumulation of apolipoprotein B-48–containing
chylomicron remnants on low-fat diet, which was signiﬁcantly accentuated upon feeding a high-fat,
high-cholesterol diet. APOE/ minipigs displayed accelerated progressive atherosclerosis but not xanthoma
formation. This indicates that remnant lipoproteinemia does not induce early lesions but is atherogenic
in pre-existing atherosclerosis. (J Am Coll Cardiol Basic Trans Science 2017;2:591–600) © 2017 The Authors.
Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).T he most efﬁcient animal model ofexperimental atherosclerosis is theapolipoprotein E (APOE)–deﬁcient
mouse (1) which develops severe hypercho-
lesterolemia and rapid, ﬁbroatheromatous
atherosclerosis on normal chow diet. APOE is
synthesized in hepatocytes and several othercell types, and serves as a ligand for low-density recep-
tor-related protein 1–mediated clearance of apolipo-
protein B-48 (APOB-48)–containing chylomicron
remnants and low-density lipoprotein receptor
(LDLR)–mediated clearance of very-low-density lipo-
protein (VLDL) and intermediate-density lipoprotein
(IDL) (2). Due to hepatic editing of Apob mRNAs, mice
secrete APOB-48–containing VLDLs, making them
particularly dependent on APOE-mediated clearance
mechanisms (3). However, loss of several other
APOE-mediated functions may contribute to the
severe atherosclerosis phenotype of the Apoe/
mice. APOE has been shown to dampen inﬂammation,
inhibit smooth muscle cell (SMC) proliferation and
migration, and to be involved in reverse cholesterol
transport (4). Lipoproteins from Apoe/ mice alsoartment of Clinical Medicine, Aarhus University, Aarhus, Den
us, Denmark; cDepartment of Animal Science, Aarhus Universi
iversity of Denmark, Lyngby, Denmark; eDepartment of C
partment of Biomedicine, Aarhus University, Aarhus, Denmark;
f Veterinary Clinical Sciences, University of Copenhagen, Co
s Cardiovasculares Carlos III (CNIC), Madrid, Spain. Suppo
enmark, The NovoNordisk Foundation, Hellerup, Denmark, Th
il for Independent Research—Technology and Production Scien
s University, Aarhus, Denmark. The CNIC is supported by the S
CO)and theProCNICFoundation,and is a SeveroOchoaCenter
ns a patent on porcine APOE targeting with Drs. Bentzon, Søren
esen, and Bolund aremembers of the EU COSTAction BM1308 “
he Chief Scientiﬁc Ofﬁcer of PixieGene. Drs. Bentzon and Søren
est they are in compliancewith human studies committees and
Drug Administration guidelines, including patient consent whe
lational Science author instructions page.
ceived February 20, 2017; revised manuscript received June 1,more readily produce foam cells in vitro for reasons
that are not well understood (5). In humans, genetic
variants that increase remnant lipoproteins similar to
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the risk of ischemic heart disease but also the plasma
level of C-reactive protein (CRP). This is not seen
with gene variants that increase low-density lipopro-
tein (LDL); possibly reﬂecting a pro-inﬂammatory
effect of remnant lipoproteins in the arterial wall (6).
Several lines of hypercholesterolemicminipigs exist
with spontaneous or genetically engineered defects in
LDLR-mediated hepatic LDL uptake (7). These include
familial hypercholesterolemia-Bretoncelles-Meishan
pigs with a spontaneous LDLR mutation (8), human
D374Y gain-of-function proprotein convertase
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593especially in the coronary arteries, and the disease
does not reach a symptomatic stage with plaque
rupture or thrombotic events within time frames
observed so far.
In the present study, we created Yucatan minipigs
with targeted disruption of the APOE gene and
assessed the impact of accumulating remnant lipo-
proteins on the development of atherosclerosis.
METHODS
Detailed methods are available in the Supplemental
Appendix.
ANIMALS. The Danish Animal Experiments Inspec-
torate approved all procedures involving animals.
Yucatan minipigs were originally purchased from
Moran Farm Enterprises (Ballina, Ireland) and a
breeding colony was established and maintained at
Aarhus University. All animals were housed in a
speciﬁc pathogen-free stable facility under standard
conditions. The minipigs were fed a low-fat (LF)
standard pig diet until 8 weeks of age and subse-
quently a high-fat high-cholesterol (HFHC) diet con-
sisting of standard pig feed comprising 20% (w/w) of
lard and 2% cholesterol (Sigma-Aldrich, St. Louis,
Missouri) until euthanization at the age of 16 weeks
(APOE/þ) or 52 weeks (APOEþ/þ and APOE/).
CONSTRUCTION OF RECOMBINANT ADENO-ASSOCIATED
VIRUS/APOE KNOCKOUT TARGETING VECTOR. As human
APOE, the porcine APOE gene consists of 4 exons
and the porcine protein has an amino acid similarity of
70.3% compared to human APOE (11,12). The recom-
binant adeno-associated virus (rAAV)/APOE knockout
(KO) vector was constructed as previously described
(13,14). Two homology arms (w1 kb each), ﬂanking
exon 3 of the porcine APOE gene, were ampliﬁed by
polymerase chain reaction (PCR) using Yucatan mini-
pig genomic DNA as template. These 2 homology arms
were subsequently linked to a neomycin (neor)/
zeomycin (zeor) resistance gene cassette by a 3-way
fusion PCR. The neor/zeor cassette, ﬂanked by loxP
sites, was comprised in a 4-kb PvuI fragment isolated
from a plasmid called pNeDaKO-Neo (pronounced
‘p-Need a Knockout-Neo’); a generous gift from Bert
Vogelstein and Kenneth W. Kinzler, The Johns
Hopkins University Medical Institutions, Baltimore,
Maryland. The 3-way fusion PCR was performed as
described by Kohli et al. (13) using a Platinum Pfx
polymerase (Thermo Fisher Scientiﬁc, Waltham,
Massachusetts) and the following PCR protocol: 1 cy-
cle of 94C for 1 min; 25 cycles of 94C for 30 s, 59C for
30 s, and 68C for 4 min; 1 cycle of 68C for 7 min.
Fusion products were digested with NotI and ligated
to a NotI-cleaved pAAV-MCS plasmid backbone(Stratagene, San Diego, California, cat. no. 240071-5)
containing an ampicillin (amp) resistance gene and
the viral inverted terminal repeat sequences. The ﬁnal
rAAV/APOE KO plasmid construct was veriﬁed by NotI
digestions and sequencing. Successful gene targeting
using the rAAV/APOE KO vector results in deletion of
295 bp in the APOE gene including the entire exon 3.
PCR primers for generating the rAAV/APOE KO
construct are listed in Supplemental Table S1.
CLONING AND EMBRYO TRANSFER. A detailed
description of the methods used to clone piglets from
genetically modiﬁed ﬁbroblasts has been published
previously (15). Brieﬂy, after partial digestion of zona
pellucida with 3.3 mg/ml pronase, oriented bisection
of matured oocytes was performed manually under
stereomicroscope with a microblade (AB Technology,
Pullman, Western Australia, Australia). Each ooplast
was attached with an APOE KO genetically modiﬁed
ﬁbroblast and fused in fusion medium (0.3 mol
mannitol, 0.1 mmol MgSO4 and 0.01% [w/v] polyvinyl
alcohol) in a fusion chamber (BTX microslide 0.5-mm
fusion chamber, model 450; BTX Instrument Division,
Harvard Apparatus, Holliston, Massachusetts) with a
single direct current pulse of 2.0 kV/cm for 9 ms. One
hour later, each ooplast-APOE KO genetically modi-
ﬁed cell pair was fused with another ooplast in acti-
vation medium (fusion medium supplemented with
0.1 mmol CaCl2) by a single direct current pulse of
0.86 kV/cm for 80 ms. After incubation in porcine
zygote medium 3 supplemented with 5 mg/ml cyto-
chalasin B and 10 mg/ml cycloheximide for 4 h, the
reconstructed embryos were cultured individually in
well-of-the-wells made in 4-well dishes ﬁlled with
porcine zygote medium 3 medium. Morulae and
blastocysts were collected on days 5 and 6 and sur-
gically transferred to Danish Landrace sows on day 4
or 5 after heat, which were observed 5 days after
weaning. Five embryo transfers were performed with
an average of 96 reconstructed embryos transferred
per recipient sow (16). Successful pregnancies were
diagnosed in 4 of the 5 recipient sows by ultraso-
nography on day 28. A total of 34 live-born piglets
were delivered by caesarian section or vaginal birth
24 hours after induction with prostaglandin. Three of
the cloned founders survived the neonatal period and
were used for further breeding.
PATHOLOGY. Animals were intubated following
sedation with 20 mg etomidate (Janssen-Cilag A/S,
Birkerød, Denmark) intravenously, anesthetized using
propofol (infusion rate 150 mg/h, B. Braun Melsungen
AG, Melsungen, Germany) and fentanyl (infusion rate
1 mg/h, Hameln Pharmaceuticals Ltd., Gloucester,
United Kingdom), and mechanically ventilated. To
prevent clot formation, the animals were
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594anticoagulated with 10,000 IU heparin injection
intravenously before being euthanized by exsangui-
nation. Hearts, aortas and right iliofemoral arteries
were excised and immersed in 4% phosphate-buffered
formaldehyde for 24 h followed by immersion in cold
phosphate-buffered saline.
Aortas were cut open longitudinally and divided
into thoracic aorta and abdominal aorta at the site
between the 6th and 7th intercostal arteries. Aortas
and the right iliofemoral arteries were stained with
Sudan IV (Sigma-Aldrich; 5 g/l in 96% ethanol for
5 min followed by 90 s washout in 96% ethanol) and
en face images of the vessels were obtained using a
digital scanner (Epson Perfection V600 Photo, Seiko
Epson Corporation, Suwa, Nagano, Japan).
The percentage of intimal surface covered with
lesions was determined by automated computer-
assisted measurement of Sudan-IV stained (sudano-
philic) intima using ImageJ 1.48v (National Institutes
of Health, Bethesda, Maryland). Lesions in the
abdominal aorta were traced manually using ImageJ
since most lesions were less sudanophilic.
Left anterior descending (LAD) coronary arteries
were excised from the myocardium and the proximal
3 cm were divided into ﬁve 5-mm segments. The
transversal segment, containing the most raised
lesion (by macroscopic inspection) in the region
proximal to the aortic trifurcation, was also obtained
from each pig. Segments were parafﬁn-embedded
and sectioned for histological analysis. LAD sections
were stained with hematoxylin and eosin, and the
lesions in the abdominal aorta sections were stained
with elastin-trichrome.
Lesion sizes in the LAD were measured by
computer-assisted planimetry. For the aortic plaques,
maximum plaque-thickness was measured from the
internal elastic lamina to the lumen.
We performed immunohistochemical staining for
smooth muscle a-actin (SMaA) to detect SMCs in
abdominal aorta lesions. Endogenous peroxidase ac-
tivity was blocked by incubating the sections for
10 min with Hydrogen Peroxidase Block (Thermo
Fisher Scientiﬁc) followed by blocking for nonspeciﬁc
protein binding using Protein Block for 10 min. Sec-
tions were incubated with monoclonal mouse anti-
human smooth muscle alpha actin antibody (Dako
Denmark A/S, Glostrup, Denmark, cat. no. M0851,
clone 1A4 [71 mg/l]) diluted 1:200 for 1 h at room
temperature and visualized using horseradish
peroxidase-conjugated secondary antibodies (Abcam,
Cambridge, United Kingdom, EXPOSE detection IHC
kit, cat. no. ab80436), 3,30-diaminobenzidine for
7 min, and hematoxylin counterstain following the
manufacturer’s recommendations.All microscopic analyses were performed blinded.
Lesions were categorized according to the classiﬁca-
tion introduced by Virmani et al. (17) as normal,
xanthoma, or progressive atherosclerotic lesions
(pathological intimal thickening or ﬁbroatheroma).
STATISTICS. All analyses were performed using Prism
6 (GraphPad Software Inc.). To compare 2 groups,
we used the Student t test when data were normally
distributed and Mann-Whitney U test when data
were not normally distributed. Area under the
curve was calculated by the trapezoidal method
and compared to test for differences in time serial
measurements. Plaque types were categorized as
either progressive or nonprogressive types, and the
frequency of progressive plaques was compared
between groups using Fisher’s exact test. p <0.05 was
considered signiﬁcant. In all ﬁgures, an * indicates
p < 0.05 and a ** indicates p < 0.01. Exact p values are
given in ﬁgure legends.
RESULTS
TARGETED KO OF THE PORCINE APOE GENE. APOE
comprises 2 structural domains separated by a hinge
region. The N-terminal domain (amino acids 1–191)
contains the receptor binding region and the
C-terminal domain (amino acids 225-299) harbors
the lipid binding region (18). We used rAAV-mediated
gene targeting (14,19) to create Yucatan minipigs that
lack APOE due to deletion of the entire exon 3 and
disruption of the receptor binding region. An rAAV-
APOE KO viral vector (Figure 1A) was generated to pro-
duce rAAV particles used for gene targeting in primary
porcine ﬁbroblasts isolated from newborn male Yuca-
tan minipigs. The APOEþ/ gene targeted cell clones
were validated by Southern blotting using an APOE-
speciﬁc probe located upstream of the targeted region
conﬁrming deletion of exon 3, and a neor-speciﬁc probe
detecting the neor region of the targeting vector to
validate the absence of unwanted random integrations
of the vector in the gene targeted cell clones.
CLONING OF APOE KO YUCATAN MINIPIGS. One of
the APOEþ/ gene targeted cell clones was used as
nuclear donor cells for somatic cell nuclear transfer by
handmade cloning. All piglets were genotypically
validated as APOEþ/ by Southern blotting (Figure 1B).
Three APOEþ/ founders of the 34 cloned live-born
male piglets survived the neonatal period. All 3 foun-
ders were healthy, and cytogenetical analysis per-
formed on 1 of them revealed a seemingly normal
karyotype (Supplemental Figure 1). The 3 APOEþ/
Yucatan boars were mated with wild-type Yucatan
sows to obtain naturally bred F1 (APOEþ/) in-
dividuals. The F1 minipigs were interbred to obtain F2
FIGURE 1 APOE Gene Targeting
(A) Schematic representation of the endogenous APOE locus, the gene targeting vector and the targeted APOE locus. The exons of the
endogenous porcine APOE gene are shown as black boxes. Expression of the neor cDNA cassette is driven by a PGK promoter, whereas
expression of the zeor cDNA cassette used for bacterial selection is driven by an EM7 promoter. A region of 295 bp in APOE, comprising the
entire exon 3 and its ﬂanking regions, is upon successful gene targeting replaced by the PGK-neor-EM7-zeor cassette resulting in a targeted
DNA-fragment of 5,530 bp when XmnI-digested genomic DNA is hybridized with the APOE- or neor-speciﬁc probe. Positions of the PCR
screening primer pairs F1/R1 and F2/R2 are indicated by small horizontal arrows. XmnI restriction sites are indicated by vertical arrows and
Southern blot probes (APOE probe and neor probe) are illustrated as black horizontal bars. (B) Representative Southern blot of genomic DNA
isolated from cloned APOEþ/ Yucatan minipigs. XmnI-digested genomic DNA was electrophoresed, blotted on to a nitrocellulose membrane,
and hybridized with the APOE probe resulting in a 5.5 kb and a 11.9 kb band representing the targeted and the wild-type allele, respectively
(upper panel). The genomic DNA was also hybridized with the neor probe, detecting the neor cassette, yielding only the expected targeted
5.5 kb band (lower panel). Lanes 1-6: Genomic DNA from representative cloned APOEþ/ Yucatan minipigs. Lane 7: Yucatan APOEþ/þ control
minipig. (C) Reverse transcriptase PCR. Total RNA was isolated from liver tissue and used for ﬁrst strand cDNA synthesis. RT-PCR was
performed using primers speciﬁc for the APOE exon 3 region or the porcine b-actin gene ACTB. PGK ¼ phosphoglycerate kinase;
PCR ¼ polymerase chain reaction; RT-PCR ¼ reverse transcriptase polymerase chain reaction.
J A C C : B A S I C T O T R A N S L A T I O N A L S C I E N C E V O L . 2 , N O . 5 , 2 0 1 7 Shim et al.
O C T O B E R 2 0 1 7 : 5 9 1 – 6 0 0 APOE-KO in Minipigs Accelerates Atherosclerosis
595APOEþ/þ, APOEþ/, and APOE/ minipigs including 6
male APOEþ/þ, 6 male APOE/, 7 male APOEþ/, 7 fe-
maleAPOEþ/þ, 7 femaleAPOEþ/, and 5 femaleAPOE/
minipigs which were included in the study. The ex-
pected level of APOE expression in the 3 different ge-
notypes was validated by reverse transcriptase PCR
performed on liver tissue isolated from the minipigs at
euthanization (Figure 1C, Supplemental Figure 2).
ACCUMULATION OF CHYLOMICRON REMNANTS. At
8 weeks of age, when the animals were fed a LF
standard diet, APOE/ minipigs exhibited signiﬁ-
cantly higher total cholesterol (4.28  0.31 mmol/l)
compared to both APOEþ/ (1.60  0.08 mmol/l) and
APOEþ/þ(1.81  0.08 mmol/l) (p <0.001). Size-
exclusion chromatography (Figure 2A, left column)
and ultracentrifugation (Figure 2B, left column)
showed that this was explained by accumulation of
lipoproteins of IDL/VLDL size and density. TheAPOE/ phenotype was intensiﬁed after 8 weeks on
HFHC diet (Figure 2A, right column and Figure 2B,
right column). Western blot of APOB showed accu-
mulation of APOB-48 in APOE/ pigs on LF diet and
accentuated APOB-48 accumulation after HFHC diet
feeding (Figure 2C, Supplemental Figure 3). This in-
dicates that the accumulating lipoproteins were
chylomicron remnants because pigs, like humans,
only produce APOB-48–containing lipoproteins in the
small intestine (20).
PERSISTENT INCREASE IN REMNANT CHOLESTEROL.
To induce atherosclerosis, APOEþ/þ and APOE/
minipigs were fed an HFHC diet until euthanization
at the age of 52 weeks. At this age, mean weights were
55.2  3.5 kg for male APOEþ/þ, 48.7  2.9 kg for male
APOE/ (p ¼ 0.331), 59.1  3.1 kg for female APOEþ/þ,
and 58.8  4.04 kg for female APOE/ minipigs
(p ¼ 0.899). Total cholesterol rose rapidly in APOE/
FIGURE 2 Characterization of Cholesterol Proﬁles and Inﬂammatory Markers
(A) Size-exclusion chromatography on plasma pools of cholesterol in APOEþ/þ, APOEþ/, and APOE/ Yucatan male and female minipigs on
low-fat (LF) diet (left column) and after 8 weeks on high-fat high-cholesterol (HFHC) diet (right column). (B) Ultracentrifugation charac-
terization of cholesterol on plasma pools from APOEþ/þ and APOE/ Yucatan minipigs on LF diet (left) and after 8 weeks on HFHC diet
(right). (C) Western blot of APOB in plasma from APOEþ/þ, APOEþ/, and APOE/ Yucatan minipigs on LF diet (upper) and on HFHC diet
(lower). (D) Enzymatic measurement of total cholesterol at 8 (on LF diet), 16, 26, 36, and 52 (all on HFHC diet) weeks of age. **p ¼ 0.0022
for APOEþ/þ male versus APOE/ male minipigs and p ¼ 0.0051 for APOEþ/þ female versus APOE/ female minipigs. (E) Enzymatic
measurement of triglycerides at 8 (on LF diet), 16, 26, 36, and 52 (all on HFHC diet) weeks of age. **p ¼ 0.0087 for APOEþ/þ male versus
APOE/ male minipigs. (F) Ultracentrifugation characterization of cholesterol in plasma from APOEþ/þ, APOEþ/, and APOE/ Yucatan
minipigs on HFHC diet at 52 weeks of age. **p ¼ 0.0022 for IDL/VLDL between APOEþ/þ male and APOE/ male minipigs and p ¼ 0.0025
for IDL/VLDL between APOEþ/þ female and APOE/ female minipigs. p ¼ 0.0303 for HDL and p ¼ 0.0025 for LDL between APOEþ/þ female
and APOE/ female minipigs. (G) C-reactive protein (CRP) (left) and haptoglobin (right) levels in APOEþ/þ and APOE/ Yucatan minipigs at
8, 16, and 52 weeks of age. *p ¼ 0.0411 for APOEþ/þ male versus APOE/ male minipigs. (D to G) APOEþ/þ males n ¼ 6, APOEþ/þ females
n ¼ 7, and APOE/ males n ¼ 6, and APOE/ females n ¼ 5. Error bars indicate SEM. HDL ¼ high-density lipoprotein; IDL ¼ intermediate-
density lipoprotein; VLDL ¼ very-low-density lipoprotein.
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596minipigs after 8 weeks on HFHC diet and remained
higher throughout the whole period at a level
z18 mmol/l compared with APOEþ/þ minipigs that
reached a level z10 mmol/l (Figure 2D). The differ-
ences were statistically highly signiﬁcant when
comparing areas under the curve. Triglycerides were
also numerically higher in APOE/minipigs, although
only statistically signiﬁcant in male minipigs(Figure 2E). Lipoprotein ultracentrifugation performed
on plasma obtained at 52 weeks of age showed
signiﬁcantly increased IDL/VLDL sub-fractions of
cholesterol in APOE/ compared with APOEþ/þ mini-
pigs (Figure 2F). Female APOE/ minipigs had
signiﬁcantly lower LDL and high-density lipoprotein
(HDL) cholesterol compared with APOEþ/þ female
minipigs.
FIGURE 3 Lesion Quantiﬁcation
(A) Average cross-sectional intima area in left anterior descending (LAD) coronary artery. (B, C) Representative examples (green dots in A) of
lesions in the LAD of an APOEþ/þ (B) and an APOE/ (C) Yucatan minipig. Arrows indicate examples of foam cells. Scale bar ¼ 100 mm. Both
are examples of xanthomas with intima containing foam cells. (D, E) Representative examples (red dots in F and G) of en face stained aortic
lesions from an APOEþ/þ (D) and an APOE/ (E) Yucatan minipig. In both, abdominal aorta is depicted left and thoracic aorta depicted right.
Red areas (stained with Sudan IV) represent lipid-rich areas of the aortic intima. (F) Surface covered with red-stained area in the thoracic
aorta (mainly non-raised lesions). (G) Surface covered with red-stained area in the abdominal aorta (mainly raised lesions). **p ¼ 0.0020.
(H) Surface covered with red-stained area in the iliofemoral arteries. **p ¼ 0.0059. In A, F to H: APOEþ/þ n ¼ 13 and APOE/ n ¼ 11. Bars
indicate median.
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597REMNANT HYPERLIPOPROTEINEMIA NOT ASSOCIATED
WITH INCREASED INFLAMMATION. Recent genetic
population studies in humans showed a link between
gene variants causing higher levels of remnant lipo-
proteins and plasma levels of CRP in humans (6), but
neither CRP nor haptoglobin, another acute phase
reactant, was signiﬁcantly different between APOE/
and APOEþ/þ minipigs (Figure 2G). Although levels
increased with age in female minipigs, values
were lower than those seen in pigs with infectious
disease (21).
ACCELERATED ATHEROSCLEROSIS. Atherosclerosis
was analyzed in several arterial beds in the HFHC-fed
APOE/ and APOEþ/þ minipigs. Lesions in the LAD
coronary artery were generally small and the mean
intimal area was unaffected by the lack of APOE and
the resulting remnant lipoproteinemia (Figures 3A
to 3C). Thoracic aortas were largely covered by non-
raised sudanophilic fatty streaks (Supplemental
Figures 4A and 4B). The extent, judged by en face
measurement (Figures 3D to 3F), did not differ
between APOE/ and APOEþ/þ minipigs. In contrast,
in both the abdominal aortas and iliofemoral arteries
where wild-type minipigs develop more advanced
atherosclerosis, development of lesions were
signiﬁcantly accelerated in APOE/ minipigsshowing 2.7-fold (Figure 3G) and 2.8-fold (Figure 3H,
Supplemental Figures 4C and 4D) increases in median
surface coverage in the 2 arterial beds, respectively.
We further characterized lesion types in histo-
logical sections from the LAD and abdominal aortas
(Figure 4A). In serial sections of LADs, the most
advanced lesion identiﬁed in each minipig was a
xanthoma in all APOEþ/þ minipigs except 1 female
that had a ﬁbroatheroma and was an outlier in all
atherosclerosis measurements. In APOE/ minipigs,
the most advanced lesion types were xanthomas
(73%) and pathological intimal thickening (27%). The
frequency of progressive lesions (pathological
intimal thickening and ﬁbroatheroma) was not
signiﬁcantly different between APOEþ/þ and APOE/
minipigs.
Histology of the most raised lesion identiﬁed in the
distal part of the abdominal aorta (Figures 4B, 4E,
and 4F) showed normal or adaptive intimal thick-
ening (23%), xanthomas (31%), pathological intimal
thickenings (38%), and ﬁbroatheromas (8%, n ¼ 1) in
APOEþ/þ minipigs. In APOE/ minipigs, this was
signiﬁcantly skewed towards more advanced lesion
stages with all showing progressive atherosclerotic
lesions, 73% of which were pathological intimal
thickenings and 27% of which were ﬁbroatheromas.
FIGURE 4 Lesion Characterization
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(A) Plaque-classiﬁcation of the most advanced lesion in the LAD coronary artery of each animal. (B) Plaque classiﬁcation of the most raised
lesion in close proximity to the aortic trifurcation. **p ¼ 0.0059. (C) Thickness of the most raised lesion in close proximity to the aortic
trifurcation. Bars indicate median. **p ¼ 0.012. (D) Area stained positive for SMaA in the most raised lesion in close proximity to the aortic
trifurcation. Bars indicate mean. (E, F) Representative examples (red dots in C and D) of elastin trichrome stained lesions in the most raised
lesion in close proximity to the aortic trifurcation of an APOEþ/þ (E) and an APOE/ (F) Yucatan minipig. Scale bar ¼ 500 mm.
(G, H) Same lesions as in E and F, respectively, immunohistochemically stained for SMaA. (A to D) APOEþ/þ n ¼ 13 and APOE/ n ¼ 11.
SMaA ¼ smooth muscle a-actin; other abbreviation as in Figure 3.
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598Lesion thickness of the abdominal aorta plaque was
also signiﬁcantly increased in APOE/ compared
with APOEþ/þminipigs (Figure 4C). All ﬁbroatheromas
were of the thick ﬁbrous cap type and no thrombotic
complications were observed.
Finally, as APOE has been shown to regulate SMC
proliferation in mice, we addressed the possibility
that exaggerated SMC accumulation could explain
the acceleration of advanced atherosclerosis. Sec-
tions of lesions in the abdominal aortas were stained
for smooth muscle a-actin, but the percentage of
SMaA–positive area did not differ between APOE/
and APOEþ/þ minipigs (Figures 4D, 4G, and 4H)—
neither did it differ when correlated to lesion size
(data not shown).DISCUSSION
Defects or deﬁciency of APOE cause familial dys-
betalipoproteinemia in humans, characterized by
accumulations of VLDL, IDL, and chylomicron
remnants and a higher risk of premature athero-
sclerotic disease (22). Whereas the human disease
rarely becomes symptomatic before adulthood, the
same genetic defect in mice is aggressive with
rapid development of severe atherosclerosis. This is
partly explained by the higher reliance on APOE for
lipoprotein clearance in mice compared to humans
(3), and consequently the much higher plasma
cholesterol concentration resulting from its loss.
However, it is also possible that a particular
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599atherogenicity of the accumulating lipoproteins or
loss of intrinsic anti-atherosclerotic effects of APOE
identiﬁed in the mouse may contribute (4). The
Apoe/ mouse model is widely applied for experi-
mental atherosclerosis because of its rapid lesion
development, but it has an unusual etiology of
atherosclerosis and its translational value is
controversial (23).
In the present study, we created a model of dys-
betalipoproteinemia in minipigs, where the distri-
bution of lipoprotein classes and the lack of hepatic
APOB editing are closer to human physiology, and
examined the impact of remnant lipoproteinemia
caused by APOE KO on the development of athero-
sclerosis. We found that, as in APOE-deﬁcient
humans, heterozygotes generally had normal lipid
levels, but homozygotes showed large accumula-
tions of APOB-48 remnant-type lipoproteins.
Surprisingly, despite the severe remnant lip-
oproteinemia, which caused an approximate
doubling of plasma total cholesterol, the effect on
atherosclerosis development was modest and only
present in the most atherosclerosis-susceptible
arterial beds. APOE deﬁciency accelerated athero-
sclerosis in the abdominal aorta and iliofemoral ar-
teries, which are predilection sites for progressive
atherosclerosis in pigs and humans, but no effect
was detected in thoracic aortas and the LAD where
lesions were restricted to mainly xanthomas. In this
way, the phenotype of APOE/ minipigs was clearly
different from that of D374Y-PCSK9 transgenic
minipigs, which we have previously described using
a similar diet composition, genetic background and
follow-up time as in the present study. D374Y-
PCSK9 minipigs exhibited similar increases in
plasma cholesterol, but cholesterol was mainly car-
ried by APOB-100–containing LDLs and larger lipo-
proteins, and atherosclerosis was signiﬁcantly
accelerated in all arterial beds examined, including
the thoracic aorta and the LAD (9). The coronary
atherosclerosis phenotype of the APOE/ minipig
model was also much milder than reported for
several other porcine models, in which atheroscle-
rosis is driven by increases in APOB100-containing
lipoproteins, such as the diabetic Yorkshire model
and pigs with spontaneous or induced defects in
LDL-clearance (7,24). Part of the difference to those
models may also lie in the induction of diabetes,
differences in diet composition, including the use of
cholic acid to accentuate atherosclerosis, and po-
tential differences in atherosclerosis susceptibility of
the background strain.
Our ﬁndings indicate that the remnant lip-
oproteinemia of APOE/ minipigs is not efﬁcient ininitiating atherosclerosis. However, it may contribute
to further progression of pre-existing lesions, either
alone or together with the loss of direct anti-
atherogenic effects of APOE. One explanation for
the lack of effect in vascular beds with early athero-
sclerosis could be abolishment of APOE-mediated
binding of lipoproteins to intimal proteoglycans.
APOE, similar to APOB, contains motifs that facilitate
lipoprotein retention in the vascular wall (25). Loss of
this binding type may diminish the atherogenicity
of APOE-deﬁcient lipoproteins during initiation of
atherosclerosis, but the effect is likely lost with
further plaque development as has previously been
shown for APOB (26).
STUDY LIMITATIONS. Further studies are needed to
understand by which mechanisms APOE deﬁciency
accelerates progressive atherosclerotic lesions. We
addressed the possibilities that remnant lipoproteins
could exert a pro-inﬂammatory effect in the body, as
suggested by human genetic studies (6), or that loss
of APOE would lead to increased SMC proliferation,
but found no evidence that this was the underlying
explanation.
CONCLUSIONS
We showed that targeted gene KO of APOE in mini-
pigs causes severe remnant lipoproteinemia similar to
human familial dysbetalipoproteinemia. We found
that this increased progressive atherosclerotic lesions
but not xanthoma formation. Further research in this
model may pave the way for better understanding of
the pathophysiological effects of remnant lip-
oproteinemia in atherosclerosis.
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PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Remnant
cholesterol increases atherosclerosis and risk of ischemic
heart disease. Existing large-animal models of dyslipide-
mia and atherosclerosis, both diet-induced as well as
genetically modiﬁed animal models, display cholesterol
proﬁles resembling familial hypercholesterolemia.
We here report the ﬁrst large-animal model of APOE-
deﬁciency and remnant lipoproteinemia modelling the
dyslipidemia seen in patients with familial
dysbetalipoproteinemia.
TRANSLATIONAL OUTLOOK: The human-like
features of this animal model, in terms of size,
lipoprotein metabolism, and histopathological features
of atherosclerosis, may pave the way for better
understanding of dysbetalipoproteinemia and the
mechanisms involved in atherogenecity of remnant
lipoproteins observed in humans.
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